$4.570
-0.159 (-3.48%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ERNA Prediction & Forecast by Similar Chart Analysis
Alphio's ERNA stock price prediction model matches the current Ernexa Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.64 (+1.54%). The 1-week path is $4.96 (+8.46%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Ernexa Therapeutics Inc Stock?
Eterna Therapeutics Inc (ERNA) presents a compelling buy opportunity at its current price of $4.57. The stock has a favorable analyst price target of $30, indicating significant upside potential of approximately 557%. Additionally, the recent positive news regarding the validation of its anti-tumor therapy and a narrowing net loss of $5.51 million in Q1 2026, down from $8.20 million the previous year, suggests improving financial health. However, the main risk is its current year-to-date change of -84.24%, indicating high volatility and potential investor caution.
ERNA stock price ended at $4.57 on Friday, after losing -3.48%
Ernexa Therapeutics Inc (ERNA) last closed at $4.57, losing -3.48%. These facts feed the 1-day and 1-week ERNA price prediction above.
Forecast Drivers
Ernexa Therapeutics Inc (ERNA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ERNA, ranked by similarity.
Seasonality analysis for ERNA
Historically the probability of a positive August return for ERNA is 0.00%. January offers the highest probability of a positive month at 57.38%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ERNA
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $2.03 | $2.14 | $2.34 | -53.19% |
| Sep 2026 | $2.03 | $2.39 | $2.74 | -47.68% |
| Oct 2026 | $2.11 | $2.33 | $2.37 | -49.05% |
| Nov 2026 | $2.29 | $2.39 | $2.58 | -47.68% |
| Dec 2026 | $2.12 | $2.31 | $2.61 | -49.40% |
In 2026, Ernexa Therapeutics Inc (ERNA) is projected to range from $2.03 to $2.74.
Ernexa Therapeutics Inc 2026 monthly forecast
In Aug 2026, Ernexa Therapeutics Inc is projected to average $2.14, with a low of $2.03 and high of $2.34.
In Sep 2026, Ernexa Therapeutics Inc is projected to average $2.39, with a low of $2.03 and high of $2.74.
In Oct 2026, Ernexa Therapeutics Inc is projected to average $2.33, with a low of $2.11 and high of $2.37.
In Nov 2026, Ernexa Therapeutics Inc is projected to average $2.39, with a low of $2.29 and high of $2.58.
In Dec 2026, Ernexa Therapeutics Inc is projected to average $2.31, with a low of $2.12 and high of $2.61.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.